Publications 43 Datasets 392.5k Experiments 4.7k

Explore

43 matching publication(s)

Publication	Journal	Year	Score	Verdict
Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. PMID 37620316	Nat Commun	2023	85	L1 85/100
Targeting the epigenome and the integrated stress response to normalize colorectal cancer subclonal plasticity and progression. PMID 41963303	Cell Death Dis	2026	68	L1 68/100
Single-Cell Transcriptomic Landscape of Right-Sided Colon Cancer Reveals Cellular and Molecular Features of Metastatic Potential. PMID 41898210	Biomedicines	2026	71	L1 71/100
Enhancing cell subpopulation discovery in cancer by integrating single-cell transcriptome and expressed variants. PMID 41647537	Fundam Res	2025	68	L1 68/100
CanCellCap: robust cancer cell capture across tissue types on single-cell RNA-seq data by multi-domain learning. PMID 40739511	BMC Biol	2025	42	L1 42/100
Metabolic reprogramming and prognostic insights in molecular landscapes driven by glycolysis in ovarian cancer. PMID 40707588	Sci Rep	2025	77	L1 77/100
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer. PMID 40472802	EBioMedicine	2025	83	L1 83/100
Elucidating the Prognostic and Therapeutic Implications of Insulin Resistance Genes in Breast Cancer: A Machine Learning-Powered Analysis. PMID 40427728	Biology (Basel)	2025	84	L1 84/100
TGF-β-mediated activation of fibroblasts in cervical cancer: implications for tumor microenvironment and prognosis. PMID 40124621	PeerJ	2025	79	L1 79/100
Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers. PMID 39779736	Sci Rep	2025	74	L1 74/100
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer. PMID 39572705	Commun Biol	2024	68	L1 68/100
A platelet-related signature for predicting the prognosis and immunotherapy benefit in bladder cancer based on machine learning combinations. ⚑ PMID 39280688	Transl Androl Urol	2024	51	L1 51/100 ⚑
Involvement of N4BP2L1, PLEKHA4, and BEGAIN genes in breast cancer and muscle cell development. PMID 38859961	Front Cell Dev Biol	2024	73	L1 73/100
Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer. PMID 38435998	PeerJ	2024	67	L1 67/100
Deciphering the Immune Microenvironment at the Forefront of Tumor Aggressiveness by Constructing a Regulatory Network with Single-Cell and Spatial Transcriptomi PMID 38254989	Genes (Basel)	2024	85	L1 85/100
Refining breast cancer biomarker discovery and drug targeting through an advanced data-driven approach. PMID 38253993	BMC Bioinformatics	2024	59	59/100
Hierarchical classification-based pan-cancer methylation analysis to classify primary cancer. PMID 38066424	BMC Bioinformatics	2023	83	L1 83/100
Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer. PMID 38076064	Heliyon	2023	71	L1 71/100
Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma. PMID 37161060	Sci Rep	2023	73	L1 73/100
Clustering and machine learning-based integration identify cancer associated fibroblasts genes' signature in head and neck squamous cell carcinoma. PMID 37065499	Front Genet	2023	63	L1 63/100
Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer. PMID 36851919	Comput Struct Biotechnol J	2023	78	L2 78/100
Artificial intelligence-guided discovery of gastric cancer continuum. PMID 36692601	Gastric Cancer	2023	71	L1 71/100
Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer. PMID 36245985	J Oncol	2022	—	not yet assessed
Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression. PMID 35655723	Contrast Media Mol Imaging	2022	48	L1 48/100
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer. ⚑ PMID 35431924	Front Pharmacol	2022	45	L1 45/100 ⚑
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑
Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma. ⚑ PMID 35153296	Int J Oral Sci	2022	10	L1 10/100 ⚑
Transcriptomic-Based Quantification of the Epithelial-Hybrid-Mesenchymal Spectrum across Biological Contexts. PMID 35053177	Biomolecules	2021	100	L1 100/100
A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer. PMID 35047825	NAR Cancer	2022	100	L1 100/100
The butyrophilin 1a1 knockout mouse revisited: Ablation of Btn1a1 leads to concurrent cell death and renewal in the mammary epithelium during lactation. PMID 34938960	FASEB Bioadv	2021	98	L1 98/100
Epigenetic loss of heterogeneity from low to high grade localized prostate tumours. PMID 34911933	Nat Commun	2021	79	L1 79/100
Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods. PMID 34143800	PLoS One	2021	75	L1 75/100
Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissu PMID 34056582	Front Artif Intell	2021	92	L1 92/100
Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer. PMID 33890574	Elife	2021	76	L1 76/100
Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer. PMID 33173782	Front Mol Biosci	2020	71	L1 71/100
Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme. PMID 33072547	Front Oncol	2020	89	L1 89/100
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer. PMID 32323921	Mol Syst Biol	2020	66	L1 66/100
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer. ⚑ PMID 32365491	Cancers (Basel)	2020	35	L1 35/100 ⚑
A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles. PMID 32111252	Genome Med	2020	91	L1 91/100
Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. PMID 29983891	Oncotarget	2018	65	L1 65/100
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes. PMID 28446242	Genome Med	2017	92	L1 92/100
Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility. PMID 26538066	BMC Med Genomics	2015	83	L1 83/100
Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case. PMID 26286638	Sci Rep	2015	76	L1 76/100